The Asia Pacific Infusion Pumps & Accessories Market would witness market growth of 6.6% CAGR during the forecast period (2018 – 2024).
Infusion pumps and accessories are a set of drugs delivering devices which are used to administer medications in a controlled, precise and automated manner. These devices are for therapeutic purposes, and come handy in critical care, pain management and other applications, to administer medications on a continuous basis to ensure patients comfort and also offer pain-free therapy. Swelling demand for home-based healthcare solutions, rise in geriatric population, and increasing levels of disposable income in the developing economies would supplement the market growth. However, stringent government regulations for the approval of devices and lack of cyber security in wireless infusion pumps would limit the growth significantly.
Based on Type, the market is segmented into Accessories & Disposables and Devices & Pumps. Based on Application, the market is segmented into Gastroenterology, Diabetes, Analgesia & Pain Management, Chemotherapy, Pediatrics & Neonatology, and Other Application. Based on End User, the market is segmented into Hospitals, Home Care, Ambulatory Surgical Centers (ASCs), and Other End User. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc., Chemyx Inc., Hoffmann-la Roche Ltd., Pfizer Inc., Medtronic, Inc., Terumo Corporation, and Smiths Medical.
Scope of the Study
Market Segmentation:
By Type
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.